section name header

Evidence summaries

Antioxidants for Female Subfertility

Antioxidants might possibly be effective for improving birth rate in subfertile women compared with placebo or no treatment, but the evidence is limited. Level of evidence: "D"

Comment: The quality of evidence is downgraded by study limitations (unclear allocation concealment and unclear blinding in half othe studies, and selective reporting), by imprecise results (few patients and events for one comparison), and by inconsistency (unexplained variability in results).

Summary

A Cochrane review [Abstract] 1 included 50 studies with a total of 6 510 subjects. Oral antioxidants, including combinations of antioxidants, pentoxifylline, N-acetyl-cysteine, melatonin, L-arginine, vitamin E, myo-inositol, vitamin C, vitamin D+calcium and omega-3-polyunsaturated fatty acids were compared with placebo, with no treatment/standard treatment or another antioxidant. Antioxidants were associated with an increased live birth rate and clinical pregnancy rate compared with placebo or no treatment/standard treatment T1. This suggests that among subfertile women with an expected live birth rate of 20%, the rate among women taking antioxidants would be between 26% and 43%. Pentoxifylline was associated with an increased clinical pregnancy rate compared with placebo or no treatment (OR 2.03, 95% CI 1.19 to 3.44, P = 0.009; 3 RCTs, n=276, I²= 0%) but in one study there was no difference in live birth (OR 1.54, 95% CI 0.68 to 3.50, n=112).

Antioxidant(s) compared to placebo or no treatment/standard treatment for female subfertility

OutcomeRelative effect(95% CI)Risk with control - Placebo or no treatment/standard treatmentRisk with intervention - Antioxidant(s) (95% CI)of participants(studies) Quality of evidence
Live birthOR 2.13(1.45 to 3.12)196 per 1000342 per 1000(262 to 433)651(8) Very low
Clinical pregnancyOR 1.52(1.31 to 1.76)220 per 1000301 per 1000(270 to 332)4271(26) Very low
Adverse events - MiscarriageOR 0.79(0.58 to 1.08)68 per 100055 per 1000(41 to 73)2834(18) Very low
Adverse events - Multiple pregnancyOR 1.00(0.73 to 1.38)80 per 100080 per 1000(60 to 107)2163(8) Very low
Adverse events - Gastrointestinal disturbancesOR 1.55(0.47 to 5.10)24 per 100037per 1000(12 to 112)343(3) Very low

Date of latest search: 2018-01-22

References

  • Showell MG, Mackenzie-Proctor R, Jordan V et al. Antioxidants for female subfertility. Cochrane Database Syst Rev 2017;(7):CD007807.[PubMed]

Primary/Secondary Keywords